Literature DB >> 9699642

"Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.

G Fang1, B S Chang, C N Kim, C Perkins, C B Thompson, K N Bhalla.   

Abstract

Taxol, 1-beta-D-arabinofuranosylcytosine (ara-C), and etoposide induce apoptosis in HL-60 cells that is blocked by overexpression of Bcl-2 or Bcl-xL.A 60-amino acid "loop" domain of Bcl-2 and Bcl-xL that contains phosphorylation sites is known to negatively regulate their antiapoptotic function. In the present studies, Taxol-, ara-C-, or etoposide-induced apoptosis was examined in HL-60/Bcl-2delta and HL-60/Bcl-xLdelta cells that express the loop-deletional mutant cDNA constructs p19Bcl-2delta32-80 and p18Bcl-xLdelta26-83, respectively. This was compared with control HL-60/neo cells as well as HL-60/Bcl-2 and HL-60/Bcl-xL cells. The latter two cell lines overexpress full-length Bcl-2 and Bcl-xL, respectively. Immunoblot analyses showed that HL-60/neo and HL-60/Bcl-2delta cells express similar levels of p26Bcl-2. In contrast, as compared with HL-60/neo, HL-60/Bcl-xLdelta cells expressed significantly lower levels of p26Bcl-2. p29Bcl-xL and p21Bax levels were similar in all cell types. Exposure to etoposide (50 microM) or ara-C (100 microM) for 4 h induced apoptosis in HL-60/neo cells, but not in HL-60/Bcl-2, HL-60/Bcl-xL, HL-60/Bcl-2delta, or HL-60/Bcl-xLdelta cells. In contrast, Taxol treatment (500 nM for 24 h) triggered the molecular cascade of apoptosis, represented by the cytosolic increase of cytochrome c and poly(ADP-ribose) polymerase or the DNA fragmentation factor cleavage activity of caspase-3 in HL-60/neo cells as well as in HL-60/Bcl-xLdelta and HL-60/Bcl-2delta cells, but not in their counterparts overexpressing full-length Bcl-2 and Bcl-xL. Equal amounts of p26Bcl-2 were coimmunoprecipitated with apoptosis protease-activating factor 1 (APAF-1) in HL-60/neo and HL-60/Bcl-2delta cells, whereas a markedly higher level of p26Bcl-2 coimmunoprecipitated with APAF-1 in HL-60/Bcl-2 cells. In association with Taxol-induced apoptosis, the levels of Bcl-2 that were coimmunoprecipitated with APAF-1 declined in HL-60/neo and HL-60/Bcl-2delta cells. This was not observed in HL-60/Bcl-2 cells, in which Taxol-induced apoptosis was blocked. Previous studies have demonstrated that Taxol induces phosphorylation of Bcl-2 in association with Taxol-induced apoptosis of HL-60/neo cells. Immunoblot analysis demonstrated a Taxol-induced mobility shift of Bcl-2 but not p19Bcl-2delta. Taxol also increased [32P]Pi incorporation in p26Bcl-2, but not in p19Bcl-2delta or p18Bcl-xL. These findings indicate that the loop domain is necessary for the Taxol-induced mobility shift and phosphorylation of Bcl-2. Loop domain also seems to be necessary for the antiapoptotic effect of Bcl-2 against Taxol-induced apoptosis but not ara-C- or etoposide-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699642

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1.

Authors:  K Moriishi; D C Huang; S Cory; J M Adams
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1.

Authors:  N Pathan; C Aime-Sempe; S Kitada; S Haldar; J C Reed
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

3.  The X-linked inhibitor of apoptosis protein inhibits taxol-induced apoptosis in LNCaP cells.

Authors:  Takeo Nomura; Hiromitsu Mimata; Yusuke Takeuchi; Hideyuki Yamamoto; Eishichi Miyamoto; Yoshio Nomura
Journal:  Urol Res       Date:  2003-02-12

4.  Conformational States of the Cytoprotective Protein Bcl-xL.

Authors:  Pavel Ryzhov; Ye Tian; Yong Yao; Andrey A Bobkov; Wonpil Im; Francesca M Marassi
Journal:  Biophys J       Date:  2020-08-20       Impact factor: 4.033

5.  Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis.

Authors:  R K Srivastava; Q S Mi; J M Hardwick; D L Longo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway.

Authors:  K Breitschopf; J Haendeler; P Malchow; A M Zeiher; S Dimmeler
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.

Authors:  K Yamamoto; H Ichijo; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

8.  Taxol induces apoptosis in cortical neurons by a mechanism independent of Bcl-2 phosphorylation.

Authors:  X A Figueroa-Masot; M Hetman; M J Higgins; N Kokot; Z Xia
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

9.  Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance.

Authors:  Haiming Dai; Husheng Ding; X Wei Meng; Sun-Hee Lee; Paula A Schneider; Scott H Kaufmann
Journal:  Cancer Res       Date:  2013-10-04       Impact factor: 12.701

Review 10.  DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis.

Authors:  Estelle Schmitt; Claudie Paquet; Myriam Beauchemin; Richard Bertrand
Journal:  J Zhejiang Univ Sci B       Date:  2007-06       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.